RetinalGenix Technologies Inc. RTGN
Set alert
3.99 USD 0.00 0.00%
At close · Oct 29
4.00 Day range 4.00
3.20 52-week range 4.00
- YTD
- +24.69%
- 1 year
- +12.39%
- Open
- 4.00
- Prev close
- 3.99
- Mkt cap
- 75.19M
- Vol
- 18
- Avg vol
- 10
- EPS
- -0.11
- P/E
- 0.00
More statistics
- Low
- 4.00
- High
- 4.00
2Y chart
Signals (22)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 7, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | May 22, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| RSI: Overbought | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| RSI: Oversold | Nov 5, 2025 | 12 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| SMA: Bullish | Oct 24, 2025 | 1 year ago |
| RSI: Overbought | Oct 24, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 8, 2025 | 1 year ago |
| RSI: Oversold | Jul 21, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 24, 2025 | 1 year ago |
| RSI: Overbought | Apr 3, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 14, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 17, 2025 | 1 year ago |
| SMA: Bearish | Jan 15, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 6, 2025 | 1 year ago |
| RSI: Overbought | Jan 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 3, 2025 | 1 year ago |
News
- RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
- RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO
- RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
- RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
- RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
- RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening
- RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives
- RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
- RetinalGenix Technologies to Participate at the 37th Annual Roth Conference
- RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
Your note
Sign in to keep a note on RTGN — it syncs with the Stock Master app.